The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study - Institut Pasteur de Madagascar Accéder directement au contenu
Article Dans Une Revue The Lancet Infectious Diseases Année : 2019

The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study

Dh Ashwath Narayana
  • Fonction : Auteur
Mysore Kalappa Sudarshan
  • Fonction : Auteur
Matthew Muturi
  • Fonction : Auteur
Athman Mwatondo
  • Fonction : Auteur
Gati Wambura
  • Fonction : Auteur
Soa Fy Andriamandimby
Sarah Jayme
  • Fonction : Auteur
Johann Kotzé
  • Fonction : Auteur
Amila Gunesekera
  • Fonction : Auteur
Mirjam Laager
  • Fonction : Auteur
Joel Changalucha
  • Fonction : Auteur
Zac Mtema
  • Fonction : Auteur
Ahmed Lugelo
  • Fonction : Auteur
Kennedy Lushasi
  • Fonction : Auteur
Onphirul Yurachai
  • Fonction : Auteur
Malavika Rajeev
  • Fonction : Auteur
  • PersonId : 1041185

Résumé

Background: Tens of thousands of people die from dog-mediated rabies annually. Deaths can be prevented through post-exposure prophylaxis for people who have been bitten, and the disease eliminated through dog vaccination. Current post-exposure prophylaxis use saves many lives, but availability remains poor in many rabies-endemic countries due to high costs, poor access, and supply. Methods: We developed epidemiological and economic models to investigate the effect of an investment in post-exposure prophylaxis by Gavi, the Vaccine Alliance. We modelled post-exposure prophylaxis use according to the status quo, with improved access using WHO-recommended intradermal vaccination, with and without rabies immunoglobulin, and with and without dog vaccination. We took the health provider perspective, including only direct costs. Findings: We predict more than 1 million deaths will occur in the 67 rabies-endemic countries considered from 2020 to 2035, under the status quo. Current post-exposure prophylaxis use prevents approximately 56 000 deaths annually. Expanded access to, and free provision of, post-exposure prophylaxis would prevent an additional 489 000 deaths between 2020 and 2035. Under this switch to efficient intradermal post-exposure prophylaxis regimens, total projected vaccine needs remain similar (about 73 million vials) yet 17·4 million more people are vaccinated, making this an extremely cost-effective method, with costs of US$635 per death averted and $33 per disability-adjusted life-years averted. Scaling up dog vaccination programmes could eliminate dog-mediated rabies over this time period; improved post-exposure prophylaxis access remains cost-effective under this scenario, especially in combination with patient risk assessments to reduce unnecessary post-exposure prophylaxis use. Interpretation: Investing in post-exposure vaccines would be an extremely cost-effective intervention that could substantially reduce disease burden and catalyse dog vaccination efforts to eliminate dog-mediated rabies. Funding: World Health Organization.
Fichier principal
Vignette du fichier
The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible.pdf (427.86 Ko) Télécharger le fichier
Origine : Publication financée par une institution
Loading...

Dates et versions

hal-02868805 , version 1 (23-06-2020)

Licence

Paternité

Identifiants

Citer

Katie Hampson, Francesco Ventura, Rachel Steenson, Rebecca Mancy, Caroline Trotter, et al.. The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study. The Lancet Infectious Diseases, 2019, 19 (1), pp.102-111. ⟨10.1016/S1473-3099(18)30512-7⟩. ⟨hal-02868805⟩
52 Consultations
49 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More